Pharmafile Logo

Lucid Group starts new trend for CME in IBD education

October 1, 2015 |  

A tailored educational event in IBD

In the first of a series of tailored educational events, Leading Edge, part of the Lucid Group kicked off AIM100 in New York. The programme is designed to support doctors to identify IBD patients with a high risk of a poor outcome. Once identified, they will be able to assign the most appropriate treatment to ensure patients have a good outcome.
You can find out more at 
http://www.lucid-group.co.uk/#!Lucid-Group-starts-new-trend-for-CME-in-IBD-education/c1a03/560cf8cc0.

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

Lucid Group’s new website is launched!

Lucid Group unveil new website...

He who dares wins

The benefits of including medical experts in your brand planning team

Does your medical education drive change in clinical practice?

How to advance outcomes for patients using a medical education process, by Jan Steele PhD, operations director, Lucid

Advance the way you work with your experts

Written by Jan Steele PhD, operations director, Lucid